From September 17 to 19, 2025, Vitafoods Asia, the most influential nutraceutical and functional food exhibition in Asia, was grandly held in Bangkok, Thailand.

Norwegian premium dietary nutrition brand NYO3 has been invited to exhibit for the second consecutive year, and together with global krill oil leader Aker BioMarine, is making the Asia debut of its innovative brain anti-aging product—NYO3 Lysophosphatidylcholines DHA Softgel. With its cutting-edge “Norway L3” phospholipid innovation portfolio, the brand attracted significant attention from industry experts and distribution partners alike.

According to a report by Grand View Research, the global marine phospholipid market is expected to surpass USD 500 million by 2030.NYO3 has joined forces with Aker BioMarine, combining their respective strengths to launch the first LPC product independently developed and manufactured by a Norwegian brand —NYO3 Lysophosphatidylcholines DHA Softgel. Leveraging NYO3’s years of expertise in the Asian market, this product will make its debut in China, a country with immense demand. On this occasion, Aker BioMarine officially granted the certification of “The only certified LPC-based Brain Gold product in China”, underscoring its technological uniqueness and market-leading position.

It features the fourth-generation LYSOVETA™ patented ingredient, with Lysophosphatidylcholine (LPC) as a phospholipid form of DHA. LPC-DHA is scientifically recognized as the most efficient form of DHA for brain absorption to date [Cui XY et al., Food Funct., 2020].

During the exhibition, NYO3 also unveiled two additional phospholipid-based anti-aging innovations — NYO3 Antarctic Supreme Phospholipids Krill Oil and NYO3 Efficient Liver Metabolism.Together with the NYO3 Lysophosphatidylcholines DHA Softgel, the three products form the “Norway L3: A New Era in Anti-Aging Nutrition” portfolio, empowering brain, liver, and lipid health with cutting-edge Norwegian science.